FDA Criticized for Working Too Closely With Biotech Company to Approve Alzheimer’s Drug
![FDA Criticized for Working Too Closely With Biotech Company to Approve Alzheimer’s Drug FDA Criticized for Working Too Closely With Biotech Company to Approve Alzheimer’s Drug](https://img.youtube.com/vi/bdfcWMNYfJ0/maxresdefault.jpg)
New findings from a congressional investigation into the Food and Drug Administration and the biotech company Biogen find that the FDA broke its own protocols to approve a new Alzheimer’s drug last year. The findings conclude that the regulator worked too closely with Biogen, despite significant concerns over the limited and side effects of the […]